162
Views
0
CrossRef citations to date
0
Altmetric
Research Articles

Pyrazole Linked-1,2,4-Oxadiazole Derivatives as Potential Pharmacological Agent: Design, Synthesis and Antimicrobial Study

, , ORCID Icon, &
Pages 3502-3521 | Received 07 Nov 2021, Accepted 21 Apr 2022, Published online: 10 May 2022

References

  • G. Bérubé, “An Overview of Molecular Hybrids in Drug Discovery,” Expert Opinion on Drug Discovery 11, no. 3 (2016): 281–85. doi:10.1517/17460441.2016.1135125.
  • M. M. Heravi and V. Zadsirjan, “Prescribed Drugs Containing Nitrogen Heterocycles: An Overview,” RSC Advances 10, no. 72 (2020): 44247–311. doi:10.1039/D0RA09198G.
  • N. Kerru, L. Gummidi, S. Maddila, K. K. Gangu, and S. B. Jonnalagadda, “A Review on Recent Advances in Nitrogen-Containing Molecules and Their Biological Applications,” Molecules 25, no. 8 (2020): 1909–51. doi:10.3390/molecules25081909.
  • K. Biernacki, M. Daśko, O. Ciupak, K. Kubiński, J. Rachon, and S. Demkowicz, “Novel 1,2,4-Oxadiazole Derivatives in Drug Discovery,” Pharmaceuticals 13, no. 6 (2020): 111–56. doi:10.3390/ph13060111.
  • K. Lu, L. Duan, B. Xu, W. Yin, D. Wu, Y. Zhao, and P. Gong, “Facile Synthesis of 3-Amino-5-April-1,2,4-Oxadiazoles via PIDA-Mediated Intramolecular Oxidative Cyclization,” RSC Advances 6, no. 59 (2016): 54277–80. doi:10.1039/C6RA08871F.
  • N. Baral, S. Mohapatra, B. P. Raiguru, N. P. Mishra, P. Panda, S. Nayak, S. K. Pandey, P. S. Kumar, and C. R. Sahoo, “Microwave-Assisted Rapid and Efficient Synthesis of New Series of Chromene-Based 1,2,4-Oxadiazole Derivatives and Evaluation of Antibacterial Activity with Molecular Docking Investigation,” Journal of Heterocyclic Chemistry 56, no. 2 (2019): 552–65. doi:10.1002/jhet.3430.
  • N. N. M. Oliveira, F. G. Santos, V. P. G. Ferrira, H. M. Araujo, C. Pessoa, R. Necolate, and R. N. Oliveira, “Focused Microwave Irradiation-Assisted Synthesis of N-Cyclohexyl-1,2,4-Oxadiazole Derivatives with Antitumor Activity,” Synthetic Communication 48, no. 19 (2018): 2522–32.
  • Y. Sajja, S. Vanguru, H. R. Vulupala, L. Nagarapu, Y. Perumal, D. Sriram, and J. B. Nanubolu, “Design, Synthesis, and In Vitro Antituberculosis Activity of Benzo[6,7]Cyclohepta[1,2-b]Pyridine-1,3,4-Oxadiazole Derivatives,” Chemical Biology & Drug Design 90, no. 4 (2017): 496–500. doi:10.1111/cbdd.12969.
  • G. Kapoor, R. Bhutani, D. P. Pathak, G. Chauhan, R. Kant, P. Grover, K. Nagarajan, and S. A. Siddiqui, “Current Advancement in the Oxadiazole-Based Scaffolds as Anticancer Agents,” Polycyclic Aromatic Compounds (2021): 1–33. doi:10.1080/10406638.2021.1886123.
  • R. Pratap and V. N. Yarovenko, “Synthesis and Antiviral Activity of 3-(β-Ribofuranosyl)-1,2,4-Oxadiazole-5-Carboxamide,” Nucleosides, Nucleotides, and Nucleic Acids 31, no. 41 (2000): 845–49. doi:10.1002/chin.200041185.
  • M. Mohammadi-Khanaposhtani, M. Mahdavi, M. Saeedi, R. Sabourian, M. Safavi, M. Khanavi, A. Foroumadi, A. Shafiee, and T. Akbarzadeh, “Design, Synthesis, Biological Evaluation, and Docking Study of Acetylcholinesterase Inhibitors: New Acridone-1,2,4-Oxadiazole-1,2,3-Triazole Hybrids,” Chemical Biology & Drug Design 86, no. 6 (2015): 1425–32. doi:10.1111/cbdd.12609.
  • C. S. Chang, W. M. Kan, C. L. Chen, K. C. Wang, and J. W. Chern, “De Sign and Synthesis of 1,2,4-Oxadiazole Derivatives as Non-Steroidal 5α-Reductase Inhibitors,” Journal of the Chinese Chemical Society 49, no. 1 (2002): 83–89. doi:10.1002/jccs.200200014.
  • J. Brahmi, S. Ghannay, S. Bakari, K. Aouadi, A. Kadri, M. Msaddek, and S. Vidal, “Unprecedented Stereoselective Synthesis of 3-Methylisoxazolidine-5-Aryl-1,2,4-Oxadiazoles via 1,3-Dipolar Cycloaddition and Study of Their in Vitro Antioxidant Activity,” Synthetic Communications 46, no. 24 (2016): 2037–44. doi:10.1080/00397911.2016.1244692.
  • T. Yan, G. Cheng, and H. Yang, “1,2,4-Oxadiazole-Bridged Polynitropyrazole Energetic Materials with Enhanced Thermal Stability and Low Sensitivity,” ChemPlusChem 84, no. 10 (2019): 1567–77. doi:10.1002/cplu.201900454.
  • J. Klingele, D. Kaase, M. Schmucker, and L. Meier, “Unexpected Coordination Behaviour of 3,5-Di(2-Pyridyl)-1,2,4-Oxadiazole,” European Journal of Inorganic Chemistry 2013, no. 28 (2013): 4931–39. doi:10.1002/ejic.201300511.
  • F. Tınmaz, I. Özer Ilhan, and S. Akkoç, “Preparation and Properties of Some New Pyrazole Derivatives,” Organic Preparations and Procedures International 53, no. 1 (2021): 89–94. doi:10.1080/00304948.2020.1846449.
  • N. Harikrishna, M. A. Isloor, K. Ananda, A. Obaid, and H.-K. Fun, “Synthesis, and Antitubercular and Antimicrobial Activity of 1′-(4-Chlorophenyl)Pyrazole Containing 3,5-Disubstituted Pyrazoline Derivatives,” New Journal of Chemistry 40, no. 1 (2016): 73–76. doi:10.1039/C5NJ02237A.
  • M. N. Matada and K. Jathi, “Pyrazole-Based Azo-Metal(II) Complexes as Potential Bioactive Agents: Synthesis, Characterization, Antimicrobial, anti-Tuberculosis, and DNA Interaction Studies,” Journal of Coordination Chemistry 72, no. 12 (2019): 1994–14. doi:10.1080/00958972.2019.1630613.
  • K. J. Sony, S. Ganguly, P. J. Kumar, R. J. Poddar, and A. J. Kumar, “Homology Model, Molecular Dynamics Simulation and Novel Pyrazole Analogs Design of Candida albicans CYP450 Lanosterol 14 α-Demethylase, a Target Enzyme for Antifungal Therapy,” Journal of Biomolecular Structure & Dynamics 35, no. 7 (2017): 1446–63. doi:10.1080/07391102.2016.1185380.
  • M. Chaudhary, N. Kumar, A. Baldi, R. Chandra, M. A. Babu, and J. Madan, “Chloro and Bromo-Pyrazole Curcumin Knoevenagel Condensates Augmented Anticancer Activity against Human Cervical Cancer Cells: Design, Synthesis, in Silico Docking and in Vitro Cytotoxicity Analysis,” Journal of Biomolecular Structure & Dynamics 38, no. 1 (2020): 200–18. doi:10.1080/07391102.2019.1578264.
  • R. Yan, X. Huang, X. Deng, and M. Song, “Synthesis and Activity Evaluation of Some Pyrazole–Pyrazoline Derivatives as Dual Anti-Inflammatory and Antimicrobial Agents,” Polycyclic Aromatic Compounds (2021): 1–14. doi:10.1080/10406638.2021.1919156.
  • E. H. El-Sayed and K. S. Mohamed, “Synthesis and anti-Inflammatory Evaluation of Some New Pyrazole, Pyrimidine, Pyrazolo[1,5-a]Pyrimidine, Imidazo[1,2-b]Pyrazole and Pyrazolo[5,1-b]Quinazoline Derivatives Containing Indane Moiety,” Polycyclic Aromatic Compounds 41, no. 5 (2021): 1077–93. doi:10.1080/10406638.2019.1653941.
  • S. M. Jagadale, Y. K. Abhale, H. R. Pawar, A. Shinde, V. D. Bobade, A. P. Chavan, D. Sarkar, and P. C. Mhaske, “Synthesis of New Thiazole and Pyrazole Clubbed 1,2,3-Triazol Derivatives as Potential Antimycobacterial and Antibacterial Agents,” Polycyclic Aromatic Compounds (2020): 1–22. doi:10.1080/10406638.2020.1857272.
  • I. Althagafi and E. Abdel-Latif, “Synthesis and Antibacterial Activity of New Imidazo[1,2-a]Pyridines Festooned with Pyridine, Thiazole or Pyrazole Moiety,” Polycyclic Aromatic Compounds (2021): 1–14. doi:10.1080/10406638.2021.1894185.
  • A. Y. Hassan, M. A. Mohamed, A. Abdel-Aziem, and A. O. Hussain, “Synthesis and Anticancer Activity of Some Fused Heterocyclic Compounds Containing Pyrazole Ring,” Polycyclic Aromatic Compounds 40, no. 4 (2020): 1280–90. doi:10.1080/10406638.2020.1764984.
  • D. A. Bakhotmah, T. E. Ali, M. A. Assiri, and I. S. Yahia, “Synthesis of Some Novel 2-{Pyrano[2,3-c]Pyrazoles-4-Ylidene}Malononitrile Fused with Pyrazole, Pyridine, Pyrimidine, Diazepine, Chromone, Pyrano[2,3-c]Pyrazole and Pyrano[2,3-d]Pyrimidine Systems as Anticancer Agents,” Polycyclic Aromatic Compounds (2020): 1–15. doi:10.1080/10406638.2020.1827445.
  • Z. Yu and D. Shi, “Synthesis and Herbicidal Activity of α-Amino Phosphonate Derivatives Containing Thiazole and Pyrazole Moieties,” Phosphorus, Sulfur, and Silicon and the Related Elements 185, no. 8 (2010): 1746–52. doi:10.1080/10426500903251373.
  • J. Rao, J. Lahiri, L. Isaacs, R. M. Weis, and G. M. Whitesides, “A Trivalent System from Vancomycin D-ala-D-Ala with Higher Affinity than Avidin.Biotin,” Science 280, no. 5364 (1998): 708–11. doi:10.1126/science.280.5364.708.
  • T. Fei, Y. Zhou, L. Huang, and F. Liu, “Synthesis and Characterization of Novel 1,2,4-Oxadiazoline Derivatives Containing Pyrazole Moiety by 1,3-Dipolar Cycloaddition,” Journal of Heterocyclic Chemistry 53, no. 5 (2016): 1640–45. doi:10.1002/jhet.2148.
  • T. Akbarzadeh, A. Rafinejad, A. Fallah-Tafti, R. Tiwari, A. Nasrolahi Shirazi, D. Mandal, K. Parang, and A. Foroumadi, “Synthesis and Evaluation of Ethyl 2,4-Dioxo-4-Arylbutanoate Derivatives as Src Kinase Inhibitors,” Journal of Sciences, Islamic Republic of Iran 26, no. 4 (2015): 321–25.
  • R. E. Khidre, B. F. Abdel-Wahab, A. A. Farahat, and H. A. Mohamed, “Synthetic Routes to Pyrazole-3(5)-Carboxylates,” Journal of Heterocyclic Chemistry 53, no. 1 (2016): 13–31. doi:10.1002/jhet.1504.
  • S. Talukdar, J. Hsu, T. Chou, and J. Fang, “Direct Transformation of Aldehydes to Nitriles Using Iodine in Ammonia Water,” Tetrahedron Letters 42, no. 6 (2001): 1103–5. doi:10.1016/S0040-4039(00)02195-X
  • T. Sahyoun, A. Arrault, and R. Schneider, “Amidoximes and Oximes: Synthesis, Structure, and Their Key Role as NO Donors,” Molecules 24, no. 13 (2019): 2470–89. doi:10.3390/molecules24132470
  • F. Zhang, Y. Wang, and S. Chiba, “Oxazoleorthogonal Aerobic Conversion of N-Benzyl Amidoximes to 1,2,4-Oxadiazoles or Quinazolinones,” Organic & Biomolecular Chemistry 11, no. 36 (2013): 6003–07. doi:10.1039/c3ob41393d
  • O. Trott and A. J. Olson, “ AutoDock Vina: Improving the Speed and Accuracy of Docking with a New Scoring Function, Efficient Optimization, and Multithreading,” Journal of Computational Chemistry 31, no. 2 (2010): 455–61. doi:10.1002/jcc.21334.
  • S. Dallakyan and A. J. Olson, “Small Molecule Library Screening by Docking with PyRx,” Methods in Molecular Biology 1263 (2015): 243–50. doi:10.1007/978-1-4939-2269-7_19.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.